Correlation of glypican-1 expression with TGF-β, BMP, and activin receptors in pancreatic ductal adenocarcinoma

Hany Kayed, Jörg Kleeff, Shereen Keleg, Xiaohua Jiang, Roland Penzel, Thomas Giese, Hanswalter Zentgraf, Markus W. Büchler, Murray Korc, Helmut Friess

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Glypican1 (GPC1) is a cell surface heparan sulfate proteoglycan that acts as a co-receptor for heparin-binding growth factors as well as for members of the TGF-β family. GPC1 plays a role in pancreatic cancer by regulating growth factor responsiveness. In view of the importance of members of the TGF-β family in pancreatic cancer, in the present study, the role of GPC1 in TGF-β, BMP and activin signaling was analyzed. Quantitative RT-PCR and immunohistochemistry were utilized to analyze GPC1 and TGF-β, BMP and activin receptor expression levels. Panc-1 and T3M4 pancreatic cancer cells were transfected in a stable manner with a GPC1 antisense expression construct. Anchorage-dependent and -independent growth was determined by MTT and soft agar assays. TGF-β1, activin-A and BMP-2 responsiveness was determined by MTT assays and immunoblotting with p21, p-Smad1, and p-Smad2 antibodies. QRT-PCR demonstrated increased GPC1 mRNA levels in pancreatic ductal adenocarcinoma (PDAC) compared to normal pancreatic tissues (NPT), as described previously. There was a significant correlation between GPC1 mRNA levels and TβRII, act-R1a, act-R1b, act-R2a, BMP-R1a, and BMP-R2 mRNA expression in NPT. In contrast, GPC1 mRNA expression correlated directly with act-R1a and BMP-R1a in N0 PDAC cases and with act-R2a and BMP-R1a in lymph node positive cases. Down-regulation of GPC1 resulted in increased doubling time in Panc-1 but not in T3M4 cells, and decreased anchorage-independent growth in both cell lines. GPC1 down-regulation resulted in a slightly altered response towards TGF-β1, activin-A and BMP-2 in terms of growth, p21 induction and Smad2 phosphorylation. In conclusion, enhanced GPC1 expression correlates with BMP and activin receptors in pancreatic cancer. GPC1 down-regulation suppresses pancreatic cancer cell growth and slightly modifies signaling of members of the TGF-β family of growth factors.

Original languageEnglish (US)
Pages (from-to)1139-1148
Number of pages10
JournalInternational Journal of Oncology
Volume29
Issue number5
StatePublished - Nov 2006
Externally publishedYes

Fingerprint

Glypicans
Activin Receptors
Bone Morphogenetic Protein Receptors
Pancreatic Neoplasms
Adenocarcinoma
Messenger RNA
Down-Regulation
Growth
Intercellular Signaling Peptides and Proteins
Fibroblast Growth Factor Receptors
Activins
Polymerase Chain Reaction
Heparan Sulfate Proteoglycans
Immunoblotting
Agar
Lymph Nodes
Immunohistochemistry
Phosphorylation
Cell Line
Antibodies

Keywords

  • Activin
  • Bone morphogenic protein
  • Glypican
  • Heparan sulfate proteoglycans
  • TGF-β1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kayed, H., Kleeff, J., Keleg, S., Jiang, X., Penzel, R., Giese, T., ... Friess, H. (2006). Correlation of glypican-1 expression with TGF-β, BMP, and activin receptors in pancreatic ductal adenocarcinoma. International Journal of Oncology, 29(5), 1139-1148.

Correlation of glypican-1 expression with TGF-β, BMP, and activin receptors in pancreatic ductal adenocarcinoma. / Kayed, Hany; Kleeff, Jörg; Keleg, Shereen; Jiang, Xiaohua; Penzel, Roland; Giese, Thomas; Zentgraf, Hanswalter; Büchler, Markus W.; Korc, Murray; Friess, Helmut.

In: International Journal of Oncology, Vol. 29, No. 5, 11.2006, p. 1139-1148.

Research output: Contribution to journalArticle

Kayed, H, Kleeff, J, Keleg, S, Jiang, X, Penzel, R, Giese, T, Zentgraf, H, Büchler, MW, Korc, M & Friess, H 2006, 'Correlation of glypican-1 expression with TGF-β, BMP, and activin receptors in pancreatic ductal adenocarcinoma', International Journal of Oncology, vol. 29, no. 5, pp. 1139-1148.
Kayed, Hany ; Kleeff, Jörg ; Keleg, Shereen ; Jiang, Xiaohua ; Penzel, Roland ; Giese, Thomas ; Zentgraf, Hanswalter ; Büchler, Markus W. ; Korc, Murray ; Friess, Helmut. / Correlation of glypican-1 expression with TGF-β, BMP, and activin receptors in pancreatic ductal adenocarcinoma. In: International Journal of Oncology. 2006 ; Vol. 29, No. 5. pp. 1139-1148.
@article{01f386f88e9345dca2cc6db86c93038b,
title = "Correlation of glypican-1 expression with TGF-β, BMP, and activin receptors in pancreatic ductal adenocarcinoma",
abstract = "Glypican1 (GPC1) is a cell surface heparan sulfate proteoglycan that acts as a co-receptor for heparin-binding growth factors as well as for members of the TGF-β family. GPC1 plays a role in pancreatic cancer by regulating growth factor responsiveness. In view of the importance of members of the TGF-β family in pancreatic cancer, in the present study, the role of GPC1 in TGF-β, BMP and activin signaling was analyzed. Quantitative RT-PCR and immunohistochemistry were utilized to analyze GPC1 and TGF-β, BMP and activin receptor expression levels. Panc-1 and T3M4 pancreatic cancer cells were transfected in a stable manner with a GPC1 antisense expression construct. Anchorage-dependent and -independent growth was determined by MTT and soft agar assays. TGF-β1, activin-A and BMP-2 responsiveness was determined by MTT assays and immunoblotting with p21, p-Smad1, and p-Smad2 antibodies. QRT-PCR demonstrated increased GPC1 mRNA levels in pancreatic ductal adenocarcinoma (PDAC) compared to normal pancreatic tissues (NPT), as described previously. There was a significant correlation between GPC1 mRNA levels and TβRII, act-R1a, act-R1b, act-R2a, BMP-R1a, and BMP-R2 mRNA expression in NPT. In contrast, GPC1 mRNA expression correlated directly with act-R1a and BMP-R1a in N0 PDAC cases and with act-R2a and BMP-R1a in lymph node positive cases. Down-regulation of GPC1 resulted in increased doubling time in Panc-1 but not in T3M4 cells, and decreased anchorage-independent growth in both cell lines. GPC1 down-regulation resulted in a slightly altered response towards TGF-β1, activin-A and BMP-2 in terms of growth, p21 induction and Smad2 phosphorylation. In conclusion, enhanced GPC1 expression correlates with BMP and activin receptors in pancreatic cancer. GPC1 down-regulation suppresses pancreatic cancer cell growth and slightly modifies signaling of members of the TGF-β family of growth factors.",
keywords = "Activin, Bone morphogenic protein, Glypican, Heparan sulfate proteoglycans, TGF-β1",
author = "Hany Kayed and J{\"o}rg Kleeff and Shereen Keleg and Xiaohua Jiang and Roland Penzel and Thomas Giese and Hanswalter Zentgraf and B{\"u}chler, {Markus W.} and Murray Korc and Helmut Friess",
year = "2006",
month = "11",
language = "English (US)",
volume = "29",
pages = "1139--1148",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Correlation of glypican-1 expression with TGF-β, BMP, and activin receptors in pancreatic ductal adenocarcinoma

AU - Kayed, Hany

AU - Kleeff, Jörg

AU - Keleg, Shereen

AU - Jiang, Xiaohua

AU - Penzel, Roland

AU - Giese, Thomas

AU - Zentgraf, Hanswalter

AU - Büchler, Markus W.

AU - Korc, Murray

AU - Friess, Helmut

PY - 2006/11

Y1 - 2006/11

N2 - Glypican1 (GPC1) is a cell surface heparan sulfate proteoglycan that acts as a co-receptor for heparin-binding growth factors as well as for members of the TGF-β family. GPC1 plays a role in pancreatic cancer by regulating growth factor responsiveness. In view of the importance of members of the TGF-β family in pancreatic cancer, in the present study, the role of GPC1 in TGF-β, BMP and activin signaling was analyzed. Quantitative RT-PCR and immunohistochemistry were utilized to analyze GPC1 and TGF-β, BMP and activin receptor expression levels. Panc-1 and T3M4 pancreatic cancer cells were transfected in a stable manner with a GPC1 antisense expression construct. Anchorage-dependent and -independent growth was determined by MTT and soft agar assays. TGF-β1, activin-A and BMP-2 responsiveness was determined by MTT assays and immunoblotting with p21, p-Smad1, and p-Smad2 antibodies. QRT-PCR demonstrated increased GPC1 mRNA levels in pancreatic ductal adenocarcinoma (PDAC) compared to normal pancreatic tissues (NPT), as described previously. There was a significant correlation between GPC1 mRNA levels and TβRII, act-R1a, act-R1b, act-R2a, BMP-R1a, and BMP-R2 mRNA expression in NPT. In contrast, GPC1 mRNA expression correlated directly with act-R1a and BMP-R1a in N0 PDAC cases and with act-R2a and BMP-R1a in lymph node positive cases. Down-regulation of GPC1 resulted in increased doubling time in Panc-1 but not in T3M4 cells, and decreased anchorage-independent growth in both cell lines. GPC1 down-regulation resulted in a slightly altered response towards TGF-β1, activin-A and BMP-2 in terms of growth, p21 induction and Smad2 phosphorylation. In conclusion, enhanced GPC1 expression correlates with BMP and activin receptors in pancreatic cancer. GPC1 down-regulation suppresses pancreatic cancer cell growth and slightly modifies signaling of members of the TGF-β family of growth factors.

AB - Glypican1 (GPC1) is a cell surface heparan sulfate proteoglycan that acts as a co-receptor for heparin-binding growth factors as well as for members of the TGF-β family. GPC1 plays a role in pancreatic cancer by regulating growth factor responsiveness. In view of the importance of members of the TGF-β family in pancreatic cancer, in the present study, the role of GPC1 in TGF-β, BMP and activin signaling was analyzed. Quantitative RT-PCR and immunohistochemistry were utilized to analyze GPC1 and TGF-β, BMP and activin receptor expression levels. Panc-1 and T3M4 pancreatic cancer cells were transfected in a stable manner with a GPC1 antisense expression construct. Anchorage-dependent and -independent growth was determined by MTT and soft agar assays. TGF-β1, activin-A and BMP-2 responsiveness was determined by MTT assays and immunoblotting with p21, p-Smad1, and p-Smad2 antibodies. QRT-PCR demonstrated increased GPC1 mRNA levels in pancreatic ductal adenocarcinoma (PDAC) compared to normal pancreatic tissues (NPT), as described previously. There was a significant correlation between GPC1 mRNA levels and TβRII, act-R1a, act-R1b, act-R2a, BMP-R1a, and BMP-R2 mRNA expression in NPT. In contrast, GPC1 mRNA expression correlated directly with act-R1a and BMP-R1a in N0 PDAC cases and with act-R2a and BMP-R1a in lymph node positive cases. Down-regulation of GPC1 resulted in increased doubling time in Panc-1 but not in T3M4 cells, and decreased anchorage-independent growth in both cell lines. GPC1 down-regulation resulted in a slightly altered response towards TGF-β1, activin-A and BMP-2 in terms of growth, p21 induction and Smad2 phosphorylation. In conclusion, enhanced GPC1 expression correlates with BMP and activin receptors in pancreatic cancer. GPC1 down-regulation suppresses pancreatic cancer cell growth and slightly modifies signaling of members of the TGF-β family of growth factors.

KW - Activin

KW - Bone morphogenic protein

KW - Glypican

KW - Heparan sulfate proteoglycans

KW - TGF-β1

UR - http://www.scopus.com/inward/record.url?scp=34548822519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548822519&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 1139

EP - 1148

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -